These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36058508)

  • 21. Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility.
    El-Mowafy AM; Abdel-Dayem MA; Abdel-Aziz A; El-Azab MF; Said SA
    Biochim Biophys Acta; 2011; 1811(7-8):460-7. PubMed ID: 21571092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
    Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
    Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin ameliorates sodium valproate-induced hepatotoxicity in rats.
    Oztopuz O; Turkon H; Buyuk B; Coskun O; Sehitoglu MH; Ovali MA; Uzun M
    Mol Biol Rep; 2020 Jan; 47(1):317-325. PubMed ID: 31624995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA.
    Aires CC; van Cruchten A; Ijlst L; de Almeida IT; Duran M; Wanders RJ; Silva MF
    J Hepatol; 2011 Aug; 55(2):426-34. PubMed ID: 21147182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats.
    Tong V; Teng XW; Chang TK; Abbott FS
    Toxicol Sci; 2005 Aug; 86(2):427-35. PubMed ID: 15858223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia?
    Kondo T; Ishida M; Kaneko S; Hirano T; Otani K; Fukushima Y; Muranaka H; Koide N; Yokoyama M; Nakata S
    Epilepsia; 1992; 33(3):550-4. PubMed ID: 1350534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid.
    Lee MS; Lee YJ; Kim BJ; Shin KJ; Chung BC; Baek DJ; Jung BH
    Arch Pharm Res; 2009 Jul; 32(7):1029-35. PubMed ID: 19641884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen.
    Abdel-Dayem MA; Elmarakby AA; Abdel-Aziz AA; Pye C; Said SA; El-Mowafy AM
    Drugs R D; 2014 Jun; 14(2):85-94. PubMed ID: 24733439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. III. Influence of fasting.
    Löscher W; Wahnschaffe U; Hönack D; Drews E; Nau H
    Epilepsy Res; 1993 Dec; 16(3):183-94. PubMed ID: 8119269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participation of lipid transport and fatty acid metabolism in valproate sodium-induced hepatotoxicity in HepG2 cells.
    Ji Q; Shi X; Lin R; Mao Y; Zhai X; Lin Q; Zhang J
    Toxicol In Vitro; 2010 Jun; 24(4):1086-91. PubMed ID: 20371285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.
    Stephens JR; Levy RH
    Pharm Weekbl Sci; 1992 Jun; 14(3A):118-21. PubMed ID: 1502010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione depletion by valproic acid in sandwich-cultured rat hepatocytes: Role of biotransformation and temporal relationship with onset of toxicity.
    Kiang TK; Teng XW; Surendradoss J; Karagiozov S; Abbott FS; Chang TK
    Toxicol Appl Pharmacol; 2011 May; 252(3):318-24. PubMed ID: 21397622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin U prevents valproic acid-induced liver injury through supporting enzymatic antioxidant system and increasing hepatocyte proliferation triggered by inflammation and apoptosis.
    Celik E; Tunali S; Gezginci-Oktayoglu S; Bolkent S; Can A; Yanardag R
    Toxicol Mech Methods; 2021 Oct; 31(8):600-608. PubMed ID: 34420476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatotoxicity in rat following administration of valproic acid.
    Sugimoto T; Woo M; Nishida N; Takeuchi T; Sakane Y; Kobayashi Y
    Epilepsia; 1987; 28(2):142-6. PubMed ID: 3102219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Nrf2 activation and NF-κB inhibition in valproic acid induced hepatotoxicity and in diammonium glycyrrhizinate induced protection in mice.
    Jin J; Xiong T; Hou X; Sun X; Liao J; Huang Z; Huang M; Zhao Z
    Food Chem Toxicol; 2014 Nov; 73():95-104. PubMed ID: 25152329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproic acid-induced hepatotoxicity in Alpers syndrome is associated with mitochondrial permeability transition pore opening-dependent apoptotic sensitivity in an induced pluripotent stem cell model.
    Li S; Guo J; Ying Z; Chen S; Yang L; Chen K; Long Q; Qin D; Pei D; Liu X
    Hepatology; 2015 May; 61(5):1730-9. PubMed ID: 25605636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity of valproic acid in isolated rat liver mitochondria.
    Jafarian I; Eskandari MR; Mashayekhi V; Ahadpour M; Hosseini MJ
    Toxicol Mech Methods; 2013 Oct; 23(8):617-23. PubMed ID: 23819490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity.
    Siemes H; Nau H; Schultze K; Wittfoht W; Drews E; Penzien J; Seidel U
    Epilepsia; 1993; 34(2):332-46. PubMed ID: 8453944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity.
    Krähenbühl S; Mang G; Kupferschmidt H; Meier PJ; Krause M
    Gut; 1995 Jul; 37(1):140-3. PubMed ID: 7672665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.